Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02634697 · ClinicalTrials.gov registry record · NA
Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02634697: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02634697 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02634697, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an eight week multimodal Relaxation Response Resiliency Program (3RP) intervention can effectively improve symptom severity, frequency and quality of life (Q.O.L) in atrial fibrillation (AF) patients. This will be measured by a reduction in AF symptom score, perceived stress, anxiety, hostility and depression.
Interventions
- BEHAVIORAL Relaxation Response Resiliency Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02634697
The ClinicalTrials.gov registry entry for NCT02634697 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relaxation Response Resiliency Program is the first listed.
NCT02634697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02634697 about?
NCT02634697 is a clinical study titled "Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation". The purpose of this study is to determine if an eight week multimodal Relaxation Response Resiliency Program (3RP) intervention can effectively improve symptom severity, frequency and quality of life (Q.O.L) in atrial fibrillation (AF) patients. This will be measured by a reduction in AF symptom sco...
What is the current status of trial NCT02634697?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2015-04. Estimated completion is 2017-01-09.
What interventions are being tested in trial NCT02634697?
The interventions under investigation include: Relaxation Response Resiliency Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02634697?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.